BMH BRÄUTIGAM advises EVP on merger with Vitafy
BMH BRÄUTIGAM advised Euro Vital Pharma Group (EVP), a portfolio company of a fund managed by capiton AG, on the merger with Vitafy Brands.
Following the acquisitions of Principle Healthcare (November 2020) and Group Korott (June 2021), the combination of EVP Group and Vitafy forms an important step into expanding EVP’s channel and own brand access. Together with Vitafy, EVP Group manifests its positioning as a leading player in the European consumer healthcare market and an ideal platform to further grow organically and through acquisitions. In addition, Vitafy will benefit from EVP’s European retail access and own production capacities, offering significant cross-selling and insourcing potentials. Vitafy’s and EVP’s experienced management teams will jointly leverage the new Group as Europe’s leading vertically integrated, multi-channel player in the consumer healthcare sector.
Founded in Munich (2014), Vitafy Brands has grown to be a leading consumer health D2C online platform for its own brands focusing on the development and offering of functional Consumer Health OTC products for health focused customers.
Background: BMH BRÄUTIGAM has been advising capiton AG on the acquisition of EVP and, since that date, the EVP Group, among others, on the acquisition of Principle Healthcare and Group Korott.
Team BMH BRÄUTIGAM: Till Wansleben, Tina Schmidt, Jan-Peter Heyer, David Thüning (all Private Equity ǀ Corporate/M&A), Andrea Reichert-Clauß (Management Participation ǀ Merger Control)